Custom-made GMP peptides
Buyer: Radboud Universitair Medisch Centrum/Radboudumc
- Published
- 20 February 2025
- Estimated value
- €1
- Lots
- 1
- Documents
- 1
- Notice number
- 00114557-2025
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
- 33696300Reactivos químicos
Description
The Department of Medical BioSciences from Radboudumc has been award a KWF grant for the PROTECT-lynch study. The main goal of the PROTECT-lynch study is a new treatment option for LS patients significantly improving the quality of life of LS patients and most likely the prognosis (occurrence of Lynch-related cancer(s). Standard care for healthy LS patients currently consists of undergoing intensive surveillance programs that do not guarantee timely detection of one or more Lynch-related cancers at a treatable stage. The PROTECT-lynch study may change this with its preventive dendritic cell therapy. To prepare the intended dendritic cell (DC) product for the PROTECT-lynch study, several different short GMP peptides are required in drug substance (Active Pharmaceutical Ingredient, API) quality. As the Medical BioSciences department, we have extensive experience in the preparation of DC products in collaboration with the Pharmacy department, in which comparable peptides were present as important active substances. The specific peptides are always selected based on suitable targets in the intended patient population for which the treatment is being developed. In the case of the PROT…
Official publications
- TED · 00114557-2025 · 20 February 2025
- OJS · 36/2025 · 20 February 2025
Other tenders from Radboud Universitair Medisch Centrum/Radboudumc
- Marktconsultatie Aferese apparatuur Radboudumc
- Vrijwillige Transparantie Cryonaalden Radboudumc
- EA Borstimplantaten, tissue-expanders en sizers t.b.v. Radboudumc
- Marktconsultatie inhuur apothekersassistenten t.b.v. Radboudumc
- EA Meubilair t.b.v. Radboudumc
- Marktconsultatie Integrale materiaalvoorziening (technisch & facilitair & DKW) t.b.v. Radboudumc & ROC Nijmegen
- Vrijwillige transparantie Neurostimulatoren pijnbestrijding (SCS)
- Vrijwillige transparantie Peritoneaal Dialyse (PD) Radboudumc
- Vervanging sequencing technologie (t.b.v. targeted panels en amplicons)
- Deep Brain Stimulation (DBS)
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €1.
- Who is the buyer of this tender?
- The contracting authority is Radboud Universitair Medisch Centrum/Radboudumc (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new tenders from European Union matching your business, every day.